Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States

Diabetic Neuropathies: Diagnosis and Management

(2014) Gabriella Deli et al.   NEUROENDOCRINOLOGY

Effectiveness of Duloxetine Compared With Pregabalin and Gabapentin in Diabetic Peripheral Neuropathic Pain

(2013) Michael Happich et al.   CLINICAL JOURNAL OF PAIN

New and Developing Drugs for the Treatment of Neuropathic Pain in Diabetes

(2013) Roy Freeman   Current Diabetes Reports

Pharmacologic management of diabetic peripheral neuropathic pain

(2013) Shridhar Iyer et al.   EXPERT OPINION ON PHARMACOTHERAPY

Neuropathic pain in the general population: A systematic review of epidemiological studies

(2013) O. van Hecke et al.   PAIN

Management of Painful Diabetic Neuropathy: Guideline Guidance or Jungle?

(2012) Vincenza Spallone   Current Diabetes Reports

Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life

(2012) J. Boyle et al.   DIABETES CARE

Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy

(2012) Solomon Tesfaye et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Dosing Pattern Comparison Between Duloxetine and Pregabalin among Patients with Diabetic Peripheral Neuropathic Pain

(2012) Peter Sun et al.   Pain Practice

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

(2011) H. Quan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin

(2011) Yang Zhao et al.   CURRENT MEDICAL RESEARCH AND OPINION

Evidence-based guideline: Treatment of painful diabetic neuropathy-report of the american association of neuromuscular and electrodiagnostic medicine, the american academy of neurology, and the american academy of physical medicine & rehabilitation

(2011) Vera Bril et al.   MUSCLE & NERVE

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

(2010) N. Attal et al.   EUROPEAN JOURNAL OF NEUROLOGY

A Longitudinal Assessment of Painful Diabetic Peripheral Neuropathy on Health Status, Productivity, and Health Care Utilization and Cost

(2010) Marco daCosta DiBonaventura et al.   PAIN MEDICINE

Retrospective Evaluation of Clinical Characteristics, Pharmacotherapy and Healthcare Resource Use among Patients Prescribed Pregabalin or Duloxetine for Diabetic Peripheral Neuropathy in Usual Care

(2010) Mugdha Gore et al.   Pain Practice

The Relationship Between Average Daily Dose, Medication Adherence, and Health-Care Costs among Diabetic Peripheral Neuropathic Pain Patients Initiated on Duloxetine Therapy

(2010) Shih-Yin Chen et al.   Pain Practice

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain

(2009) Sibilia Quilici et al.   BMC Neurology

Neuropathic Pain

(2009) Alec B. OʼConnor   PHARMACOECONOMICS

Incidence rates and treatment of neuropathic pain conditions in the general population☆

(2008) Jeanne P. Dieleman et al.   PAIN

A Review of the Epidemiology of Painful Diabetic Peripheral Neuropathy, Postherpetic Neuralgia, and Less Commonly Studied Neuropathic Pain Conditions

(2008) Alesia Sadosky et al.   Pain Practice